CRISTIAN COARFA to Piperazines
This is a "connection" page, showing publications CRISTIAN COARFA has written about Piperazines.
Connection Strength
0.091
-
Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer. Cancer Res. 2026 Apr 02; 86(7):1707-1723.
Score: 0.054
-
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Br J Cancer. 2021 01; 124(1):191-206.
Score: 0.037